Location & Date

Pfizer
Research Technology Center,
1 PORTLAND STREET, CAMBRIDGE, MA 02139

map »
Thu. March 15, 2018
5:30 p.m. - 9:00 p.m.

Contact & Other Information

Sirimas Sudsakorn
781.434.3602
e-Mail Event Organizer
Guests: 100 to 500



  2018 Spring Meeting  
Hosted By: New England Drug Metabolism Discussion Group



Scott Biller, Ph.D.

Chief Scientific Officer

 

Agios Pharmaceuticals, Inc

Cambridge, MA USA

" Mutant IDH1 inhibitor ivosidenib: from patient to bench to clinic "

The meeting will be held at

PFIZER RESEARCH TECHNOLOGY CENTER,

1 PORTLAND STREET, CAMBRIDGE, MA 02139

 

This Meeting is Sponsored by:

 

In Vitro ADMET Laboratories, Inc. (IVAL)

Columbia, MD USA

 

If you need a Special Food Request contact:sirimas.sudsakorn@sanofi.com
'For further information, email: sirimas.sudsakorn@sanofi.com'
Registration and Cancellation Deadline: 9:00 a.m., March 13th, 2018

NO WALK-IN OR LATE REGISTRATION ACCEPTED

The Cocktail Hour will begin at 5:30PM, followed by dinner at 6:30PM

 Presentation will begin at 7:30 PM
If you cannot attend this meeting, but wish to make a donation to NEDMDG - please use the following link: 

 

https://www.events.org/NEDMDG01/donation.aspx?o=234 








Online Registration provided by Events.org ™ - (c) 2002 - Current
Online Registration | Event Management | CRM | Silent Auction | Conference Registration

For questions on this page, please contact the event organizer eMail Event Organizer
For technical issues with this page, please contact events.org at +1 (847) 513-6460 or help@events.org